At a glance
ClinicalIndex Comparison RecordStandardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Single-arm Open-label Study to Investigate the Bioavailability and Skin Absorption of CBD and THC From GT4 Technology in Healthy Adults
In Brief
A Phase 1 clinical trial evaluating CBD and THC with GT4 technology for Biological Availability and 3 related conditions. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The bioavailability of cannabinoids differs greatly for different routes of administration. When applied topically to the skin, they are absorbed through the skin or hair follicles while interacting with receptors to provide localized effects. To gain more information on the potential of this route of administration in therapeutic applications, this open-label study will investigate the skin absorption and bioavailability of CBD and THC delivered trans-dermally.
Study Details
Timeline
Interventions
A single topical dose of CBD and THC will be administered with GT4 technology. The material will be provided in a single use pre-filled syringe.